Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hydrolysis01:15

Hydrolysis

121.8K
Overview
Hydrolysis is a chemical reaction in which the addition of water breaks down a polymer into its simpler monomer units. For example, peptides break into amino acids, carbohydrates into simple sugars, and DNA into nucleotides. Enzymes often facilitate these processes.
Hydrolysis Reverses Dehydration Synthesis
Complex carbohydrates can be broken down by breaking the bonds between individual sugar units. The reaction breaks a glycosidic bond as water is added to the compound. The...
121.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparing neuroprotective drug efficacy in rodent neonatal brain injury models.

Pediatric research·2026
Same author

Sleep-Disordered Breathing in Newborns After Myelomeningocele Repair.

Pediatrics·2026
Same author

Comparing Neuroprotective Drug Efficacy in Rodent Neonatal Brain Injury Models.

bioRxiv : the preprint server for biology·2025
Same author

Research Priorities for Children With Hypoxic-Ischemic Encephalopathy or Myelomeningocele: A Survey of Parents.

Pediatric neurology·2024
Same author

Feeding and developmental outcomes after neonatal seizures-A prospective observational study.

Annals of the Child Neurology Society·2023
Same author

Beyond the Clinical Trials: Off-Protocol Therapeutic Hypothermia.

Clinics in perinatology·2022

Related Experiment Video

Updated: Jan 24, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.2K

Repurposing azithromycin for neonatal neuroprotection.

John D E Barks1, Yiqing Liu2, Lu Wang3

  • 1Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, USA. jbarks@med.umich.edu.

Pediatric Research
|May 18, 2019
PubMed
Summary

Azithromycin demonstrated neuroprotective effects in a neonatal rodent model of hypoxic-ischemic brain injury. This antibiotic improved functional outcomes and reduced brain damage, suggesting potential for clinical trials.

More Related Videos

Strategies for Study of Neuroprotection from Cold-preconditioning
16:27

Strategies for Study of Neuroprotection from Cold-preconditioning

Published on: September 2, 2010

15.2K
Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
09:31

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography

Published on: January 27, 2023

1.5K

Related Experiment Videos

Last Updated: Jan 24, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.2K
Strategies for Study of Neuroprotection from Cold-preconditioning
16:27

Strategies for Study of Neuroprotection from Cold-preconditioning

Published on: September 2, 2010

15.2K
Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
09:31

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography

Published on: January 27, 2023

1.5K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Neonatal Medicine

Background:

  • Inflammation plays a key role in neonatal hypoxic-ischemic brain injury.
  • Azithromycin, an antibiotic with anti-inflammatory properties, was investigated for neuroprotection.

Purpose of the Study:

  • To evaluate the neuroprotective efficacy of azithromycin in a neonatal rodent model of hypoxic-ischemic brain injury.

Main Methods:

  • Neonatal rats underwent carotid artery ligation and hypoxia.
  • Sensorimotor function and brain damage were assessed after azithromycin or saline treatment.
  • Various dosing regimens and treatment timings were explored.

Main Results:

  • Azithromycin administration improved functional outcomes and reduced brain damage in a dose-dependent manner.
  • Treatment efficacy decreased with delayed administration post-hypoxia.
  • Multiple azithromycin injections over 48 hours showed greater benefits than a single dose.

Conclusions:

  • Azithromycin exhibits neuroprotective effects in a neonatal rodent model of hypoxic-ischemic brain injury.
  • Further studies in complementary models are warranted to support clinical trial evaluation for neonatal neuroprotection.